PTPN11 Gene Mutation Analysis for Noonan Syndrome
Protein Tyrosine Phosphate non-receptor type 11 (PTPN11) is located on chromosome 12 (12q24.1) and contains 15 exons. The PTPN11 gene encodes for protein SHP2 which is an integral component of the RAS/MAPK pathway. The pathway regulates vital activities of the cell including cell growth, division, differentiation, and apoptosis. Mutations in the PTPN11 gene are associated with compromised development of blood vessels, bone, heart and several tissues. Ninety distinct germline PTPN11 mutations have been identified in Noonan syndrome.
Noonan syndrome (NS) is a developmental disorder characterized by short stature, craniofacial dysmorphisms, and congenital heart defects (CHD), in particular pulmonary valve stenosis (PVS). Other signs and symptoms include a broad or webbed neck, an atypical chest shape with superior and inferior pectus carinatum, cryptorchidism, various coagulation disorders, lymphatic dysplasias, and ocular abnormalities.
The diagnosis of Noonan syndrome is established in a proband with suggestive findings and a heterozygous pathogenic variant in genes BRAF, KRAS, MAP2K1, MRAS, NRAS, PTPN11, RAF1, RASA2, RIT1, RRAS2, SOS1, or SOS2 or either a heterozygous variant or biallelic pathogenic variants in LZTR1 identified by molecular genetic testing. And studies show that PTPN11 gene mutation is associated with NS. Thus, the detection of mutation in the PTPN11 gene supports the diagnosis of NS. The molecular detection of PTPN11 mutation is however challenging due to its broad mutation spectrum, and its highly polymorphic nature.
- As an aid in the diagnosis of Noonan syndrome
- Prenatal screening in a woman carrying a PTPN11 gene mutation
A positive result indicates the presence of mutations or pathogenic variants in PTPN11 gene indicating susceptibility to Noonan syndrome.
A negative result indicates the absence of mutations or pathogenic variants in the PTPN11 gene.
Negative for mutations analyzed (No mutation or pathogenic variant detected)
Whole blood collected in EDTA (lavender top tube).
Stability
- Room: 3-5 days
- Refrigerated: 7-14 days
- Frozen: unstable
- Eur J Hum Genet. 2004 Dec;12(12):1069-72. [PMID: 15470362]
- Lancet. 2013 Jan 26;381(9863):333-42. [PMID: 23312968]
- Clin Chim Acta. 2009 Nov;409(1-2):75-7. [PMID: 19737548]
- J Matern Fetal Neonatal Med. 2010 Jul;23(7):688-91. [PMID: 20064076]
- Am J Hum Genet. 2002 Jun;70(6):1555-63. [PMID: 11992261]